These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 24727459
1. Amino Acid Prodrugs: An Approach to Improve the Absorption of HIV-1 Protease Inhibitor, Lopinavir. Patel M, Mandava N, Gokulgandhi M, Pal D, Mitra AK. Pharmaceuticals (Basel); 2014 Apr 10; 7(4):433-52. PubMed ID: 24727459 [Abstract] [Full Text] [Related]
2. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir. Patel M, Sheng Y, Mandava NK, Pal D, Mitra AK. Int J Pharm; 2014 Dec 10; 476(1-2):99-107. PubMed ID: 25261710 [Abstract] [Full Text] [Related]
3. Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug. Mandal A, Pal D, Mitra AK. Int J Pharm; 2016 Oct 15; 512(1):49-60. PubMed ID: 27543355 [Abstract] [Full Text] [Related]
7. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor. Agarwal S, Pal D, Mitra AK. Int J Pharm; 2007 Jul 18; 339(1-2):139-47. PubMed ID: 17451894 [Abstract] [Full Text] [Related]
8. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach. Qin C, Chu Y, Feng W, Fromont C, He S, Ali J, Lee JB, Zgair A, Berton M, Bettonte S, Liu R, Yang L, Monmaturapoj T, Medrano-Padial C, Ugalde AAR, Vetrugno D, Ee SY, Sheriston C, Wu Y, Stocks MJ, Fischer PM, Gershkovich P. J Control Release; 2021 Jan 10; 329():1077-1089. PubMed ID: 33091528 [Abstract] [Full Text] [Related]
12. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification. Jain R, Agarwal S, Majumdar S, Zhu X, Pal D, Mitra AK. Int J Pharm; 2005 Oct 13; 303(1-2):8-19. PubMed ID: 16137847 [Abstract] [Full Text] [Related]
13. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE. Tang F, Borchardt RT. Pharm Res; 2002 Jun 13; 19(6):787-93. PubMed ID: 12134948 [Abstract] [Full Text] [Related]
15. Stereoisomeric Prodrugs to Improve Corneal Absorption of Prednisolone: Synthesis and In Vitro Evaluation. Sheng Y, Yang X, Wang Z, Mitra AK. AAPS PharmSciTech; 2016 Jun 13; 17(3):718-26. PubMed ID: 26335418 [Abstract] [Full Text] [Related]
16. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue. Gupta D, Varghese Gupta S, Dahan A, Tsume Y, Hilfinger J, Lee KD, Amidon GL. Mol Pharm; 2013 Feb 04; 10(2):512-22. PubMed ID: 23244438 [Abstract] [Full Text] [Related]
17. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. Jain R, Duvvuri S, Kansara V, Mandava NK, Mitra AK. Int J Pharm; 2007 May 24; 336(2):233-40. PubMed ID: 17207946 [Abstract] [Full Text] [Related]
19. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Darwich AS, Neuhoff S, Jamei M, Rostami-Hodjegan A. Curr Drug Metab; 2010 Nov 24; 11(9):716-29. PubMed ID: 21189140 [Abstract] [Full Text] [Related]